INJE UNIVERSITY
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Private
- Established
- 1979-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.inje.ac.kr
Efficacy, Safety and Tolerability of Split-dose of PEG Compared With NaP Solution for Colonoscopy Preparation: A Randomized, Controlled Trial
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-10-28
- Last Posted Date
- 2010-10-28
- Lead Sponsor
- Inje University
- Target Recruit Count
- 207
- Registration Number
- NCT01229800
- Locations
- π°π·
Inje University School of Medicine, Haeundae Paik Hospital, Busan, Korea, Republic of
Tamoxifen Pharmacogenetics in Asian Breast Cancer Women
- First Posted Date
- 2010-08-13
- Last Posted Date
- 2013-06-03
- Lead Sponsor
- Inje University
- Target Recruit Count
- 1000
- Registration Number
- NCT01181518
- Locations
- π°π·
Inje University, Busan, Korea, Republic of
STUDY The Effect of HNF-4A G60D Variant on the In VIVO CYP2D6 Activity By Tolterodine Pharmacokinetic Study
- First Posted Date
- 2010-08-13
- Last Posted Date
- 2010-08-13
- Lead Sponsor
- Inje University
- Target Recruit Count
- 31
- Registration Number
- NCT01181505
PGx Study to Develop and Validate the Predictive Warfarin Dosing Algorithm for Personalized Warfarin Pharmacotherapy
Completed
- Conditions
- First Posted Date
- 2010-08-10
- Last Posted Date
- 2013-06-03
- Lead Sponsor
- Inje University
- Target Recruit Count
- 405
- Registration Number
- NCT01178502
- Locations
- π°π·
Inje University, Busan, Korea, Republic of
The Clinical Course of Coronary Artery Disease in Coronary Multidetector Computed Tomographic Angiogram
- First Posted Date
- 2010-06-14
- Last Posted Date
- 2010-09-13
- Lead Sponsor
- Inje University
- Target Recruit Count
- 5000
- Registration Number
- NCT01142973
- Locations
- π°π·
Ilsan Paik hospital, Goyang, Korea, Republic of
BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL)
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2010-02-05
- Last Posted Date
- 2010-12-02
- Lead Sponsor
- Inje University
- Target Recruit Count
- 42
- Registration Number
- NCT01063439
- Locations
- π°π·
Seoul National University Hospital, Seoul, Korea, Republic of
π°π·Asan Medical Center, University of Ulsan, Seoul, Korea, Republic of
π°π·Yeonsei University Hospital, Seoul, Korea, Republic of
Evaluation of Pharmacogenetic Factors Affecting Fentanyl Requirements for Postoperative Pain Control
Completed
- Conditions
- First Posted Date
- 2009-01-19
- Last Posted Date
- 2013-06-04
- Lead Sponsor
- Inje University
- Target Recruit Count
- 204
- Registration Number
- NCT00824772
- Locations
- π°π·
Inje University Sanggye Paik Hospital, Seoul, Korea, Republic of
The Efficacy and Safety of Dexibuprofen Syrup
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-12-22
- Last Posted Date
- 2010-01-18
- Lead Sponsor
- Inje University
- Target Recruit Count
- 260
- Registration Number
- NCT00812422
- Locations
- π°π·
Inje University Sanggye Paik Hospital, Seoul, Korea, Republic of
π°π·Asan Medical Center, Seoul, Korea, Republic of
π°π·Kyung Hee University Hospital, Seoul, Korea, Republic of
Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B Patients
Phase 4
Terminated
- Conditions
- Interventions
- First Posted Date
- 2008-11-26
- Last Posted Date
- 2011-06-23
- Lead Sponsor
- Inje University
- Target Recruit Count
- 30
- Registration Number
- NCT00798460
- Locations
- π°π·
Ilsanpaik hospital, Goyang, Gyunggi, Korea, Republic of
The Effect of CYP3A Genetic Polymorphism on the Pharmacokinetics of Phosphodiesterase type5 Inhibitors in Male Subjects
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-10-07
- Last Posted Date
- 2008-10-07
- Lead Sponsor
- Inje University
- Target Recruit Count
- 21
- Registration Number
- NCT00767598
Β© Copyright 2024. All Rights Reserved by MedPath